349
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Clinical and Public Health Considerations in Urine Drug Testing to Identify and Treat Substance Use

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Barry Rosenfeld, David V. Budescu, Ying Han, Melodie Foellmi, Kenneth L. Kirsh & Steven D. Passik. (2020) Does the perceived accuracy of urine drug testing impact clinical decision-making?. Substance Abuse 41:1, pages 85-92.
Read now
Andrea G. Barthwell, Jeffrey Allgaier & Kenneth Egli. (2018) Definitive urine drug testing in office-based opioid treatment: a literature review. Critical Reviews in Toxicology 48:10, pages 815-838.
Read now

Articles from other publishers (5)

Nazila Jamshidi, Akshay Athavale, Christopher Tremonti, Catherine McDonald, Shanmugam Banukumar, Santiago Vazquez, Natasha Luquin, Marina Santiago & Bridin Murnion. (2022) Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing. British Journal of Clinical Pharmacology 89:7, pages 1938-1947.
Crossref
Kristen A Morin, John R Dabous, Frank Vojtesek & David Marsh. (2022) Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study. BMJ Open 12:10, pages e060857.
Crossref
Jasmine McEachern, Lauren Adye-White, Kelsey C. Priest, Eloise Moss, Lauren Gorfinkel, Evan Wood, Walter Cullen & Jan Klimas. (2019) Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy. International Journal of Drug Policy 64, pages 30-33.
Crossref
Eloise Moss, Jasmine McEachern, Lauren Adye-White, Kelsey C. Priest, Lauren Gorfinkel, Evan Wood, Walter Cullen & Jan Klimas. (2018) Large Variation in Provincial Guidelines for Urine Drug Screening During Opioid Agonist Treatment in Canada. Canadian Journal of Addiction 9:2, pages 6-9.
Crossref
Adam Rzetelny, Barbara Zeller, Nicholas Miller, Kenneth L. Kirsh & Steven D. Passik. (2016) Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report. Journal of Addiction Medicine 10:6, pages 443-447.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.